OncoPharm cover image

Adjuvant Pembrolizumab (NSCLC), Elacestrant, & Pirtobrutinib

OncoPharm

00:00

Intro

John Bizarro introduces OncoPharm, the episode date, and teases recent FDA updates and approvals.

Play episode from 00:00
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app